Erratum: Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of experimental & clinical cancer research : CR (2019) 38 1 (474))

Ssu Chuan Lai, Yu Ting Su, Ching Chi Chi, Yung Che Kuo, Kam Fai Lee, Yu Chih Wu, Pei Chi Lan, Muh Hwa Yang, Te Sheng Chang, Yen Hua Huang

Research output: Contribution to journalComment/debatepeer-review

3 Citations (Scopus)

Abstract

In the original publication of this article [1], labelling within Fig. 7a was incorrect. The updated figure is shown below, with 'DMT1' now corrected to read 'DNMT1'.

Original languageEnglish
Article number10
Number of pages1
JournalJournal of experimental & clinical cancer research : CR
Volume39
Issue number1
DOIs
Publication statusPublished - Jan 13 2020

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Erratum: Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of experimental & clinical cancer research : CR (2019) 38 1 (474))'. Together they form a unique fingerprint.

Cite this